Syapse, FDA, and Advocate Aurora Health to Present Pneumonitis Safety Data in Plenary Talk at AACR Virtual Meeting
April 27, 2020 08:00 ET
|
Syapse
Data presented demonstrates that patients with a past medical history of pneumonitis had a higher incidence of treatment associated pneumonitis in both clinical trial and real-world data AACR Virtual...
Syapse Appoints Kirk Fjeldheim as Chief Information Security Officer
January 28, 2020 08:00 ET
|
Syapse
SAN FRANCISCO, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Syapse today announced the appointment of Kirk Fjeldheim as Chief Information Security Officer (CISO). As CISO, Fjeldheim will be responsible for...
Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer
October 16, 2019 08:26 ET
|
Syapse
SAN FRANCISCO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Syapse today announced the appointment of Thomas D. Brown, MD, MBA as its first Chief Medical Officer. Dr. Brown, an internationally renowned...
Syapse Appoints Fletcher Payne as Chief Financial Officer
September 10, 2019 08:00 ET
|
Syapse
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Syapse, a company accelerating precision medicine through insights derived from its global health system network, today announced that Fletcher...
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
August 14, 2019 06:00 ET
|
Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...
Seoul National University Hospital and Syapse Sign Multi-Year Renewal Agreement to Expand Access to Precision Medicine in South Korea
August 06, 2019 08:00 ET
|
Syapse
Syapse and SNUH will work together to build Asia’s first learning health network of real-world data derived from the region’s leading precision oncology hospitals Co-hosted symposium of East Asian...
Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence
July 23, 2019 08:00 ET
|
Syapse
SAN FRANCISCO, July 23, 2019 (GLOBE NEWSWIRE) -- Syapse, a company accelerating precision medicine through insights derived from its global health system network, today announced that it has entered...
Syapse Oncology Platform Achieves HITRUST CSF® Certification
April 10, 2019 08:00 ET
|
Syapse
SAN FRANCISCO, April 10, 2019 (GLOBE NEWSWIRE) -- Syapse, the leader in powering precision medicine through a global health system network, today announced that the Syapse Oncology platform has...
Syapse Presents Data Demonstrating the Effectiveness of its Real-World Data Platform in Harmonizing Molecular Testing Results Across Commercial and Hospital-based Laboratories at Scale
April 01, 2019 07:50 ET
|
Syapse
SAN FRANCISCO, April 01, 2019 (GLOBE NEWSWIRE) -- Syapse, the leader in powering precision medicine through a global health system network, today announced the presentation of data validating the...
Syapse Hosts Inaugural Precision Medicine Council to Drive Progress in Precision Oncology
October 18, 2018 13:00 ET
|
Syapse
Nation’s leading health systems convene today to share best practices and improve cancer care SAN FRANCISCO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, is...